Author Archive: Daniel Seaton

Daniel Seaton

Daniel Seaton is Manager of Event & Health Communications, working on communications for BIO’s events and health care policy issues. Prior to joining BIO in August 2013, he spent four years in communications at the Pharmaceutical Research and Manufacturers of America. The best part of his job is educating audiences about the many benefits the bioscience industry produces for patients, consumers, and the economy as a whole. Daniel enjoys hiking, camping, and, when he can find a game, playing bridge. Having grown up in New Mexico, one of his favorite foods is roasted green chile. He recently completed a Master’s degree in communications at Georgetown University.

Latest Posts

BIO Innovation Zone Company Snapshot: Arytha Biosciences

BIO Innovation Zone

Next month in Philadelphia at the BIO International Convention, BIO will be partnering with the National Science foundation (NSF) and the National Institutes of Health (NIH) to host the 2nd annual, newly-expanded BIO Innovation Zone. The Zone will feature Small Business Innovation Research (SBIR) funded early-stage biotech companies. The SBIR/STTR program provides U.S. federal funding to small businesses engaged in research with the potential for commercialization. Each of the companies has been rigorously vetted through Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

BIO 2015 to Feature Legendary Musician Wynton Marsalis

w-marsalis

With only 19 more days to go until BIO Convention 2015, BIO is excited to announce today that legendary musician Wynton Marsalis will participate in our first-ever evening Keynote at this year’s Convention!  Marsalis will be interviewed by broadcast journalist Forrest Sawyer at Philadelphia’s Convention Center on June 17th. Marsalis is known as the first jazz artist to perform and compose across the full jazz spectrum – everything from jazz’s New Orleans roots to bebop Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Morning Consult: Right-Sized Regulations, Innovation and Investor Protection

Jim Greenwood

Today, an op-ed from BIO President and CEO Jim Greenwood appeared in Morning Consult stressing the importance of investor protection by reforming eXtensible Business Reporting Language (XBRL), which is a one-size-fits-all costly reporting requirement that can harm company growth and investor returns. Congressman Robert Hurt (R-VA) introduced a bill – the Small Company Disclosure Simplification Act (H.R. 1965) – that would provide a temporary exemption from XBRL for newly public and low-revenue companies in order Read More >

Business and Investments, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Innovation Zone Company Snapshots: ONL Therapeutics and Lipella Pharmaceuticals

BIO Innovation Zone

Next month in Philadelphia at the BIO International Convention, BIO will be partnering with the National Institutes of Health (NIH) and the National Science foundation (NSF) to host the 2nd annual, newly-expanded BIO Innovation Zone. The Zone will feature Small Business Innovation Research (SBIR) funded early-stage biotech companies. The SBIR/STTR program provides U.S. federal funding to small businesses engaged in research with the potential for commercialization. Each of the companies has been rigorously vetted through the SBIR/STTR review process prior Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO Innovation Zone Company Snapshot: Nanofiber Separations

BIO Innovation Zone

Next month in Philadelphia at the BIO International Convention, BIO will be partnering with the National Science foundation (NSF) and the National Institutes of Health (NIH) to host the 2nd annual, newly-expanded BIO Innovation Zone. The Zone will feature Small Business Innovation Research (SBIR) funded early-stage biotech companies. The SBIR/STTR program provides U.S. federal funding to small businesses engaged in research with the potential for commercialization. Each of the companies has been rigorously vetted through the SBIR/STTR review Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,